Recent Comments
- Peter Ticktin on New paper explains the mysterious rubbery clots inside of vessels after COVID shots
- Mandy on The Intentional Destruction of Life on Earth
- Charles Carroll on Daily Alcohol is Not OK
- Charles Carroll on A food-borne illness mystery and what is wrong with current medical schools
- Is Italian flour healthier than American? | Quality of Life Clinic on Celiac disease is not reduced by breast feeding or delaying the introduction of gluten
Most Viewed Posts
- Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market (41,870)
- Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA (23,570)
- The Healthcare Channel hits 10 (20,841)
- New treatment paradigm for C. Diff colitis (18,845)
- How the FDA regulates compounding pharmacies (18,271)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (18,063)
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (17,539)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (16,857)
- The new CDC guidelines for prescribing opioid pain pills (14,715)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (14,284)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Nutrition
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Otolaryngology
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Wellness and Prevention
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Category Archives: – Pharma
How ADHD became such a prevalent condition
October 7, 2009- interviewed by Steven E. Greer Authors of “ADHD: medicating children”, Rick Mayes and Catherine Bagwell, discuss the history of ADHD
This could be the best interview ever aired on Fox Business
August 15, 2017- by Steven E. Greer, MD Martin Shkreli was on Fox Business today, and the set seemed familiar. Ironically, I was in this same
Posted in - Biotech, - Generics, - Medical Devices, - Opinion, - Pharma, - Policy
Leave a comment
CheckMate 026: Why did Opdivo (nivolumab) fail in NSCLC?
September 1, 2016- Interviewed by Steven E. Greer, MD In the wake of the news-making failure of CheckMate 026 of Bristol-Myers Squibb’s Opdivo (nivolumab) fail in
Posted in - Biotech, - Pharma, Oncology, UCLA
Leave a comment
The Biggest Healthcare Stories of 2016
December 26, 2016- by Steven E. Greer, MD for The Healthcare Channel Policy changes dominated the 2016 year in healthcare news. There were few important new drug
Posted in - Biotech, - Generics, - Medical Devices, - Opinion, - Pharma, - Policy, - The Weekly Summary, CMS, FDA
Leave a comment
Ibrance (palbociclib) to treat advanced breast cancer
November 28, 2016- Interviewed by Steven E. Greer, MD We interviewed Richard Finn,
The Biggest stories of 2015
December 31, 2015- by Steven E. Nike Roshe Run Femme Greer, MD 2015 was the year of ISIS. The radical jihadist group started the year with an attack in France,
Robert De Niro gives credibility to vaccine truthers
Update March 27, 2016- Less than 24-hours after our story, this film has been pulled from the lineup. It was our story that got the heads of
Posted in - Pharma, - Reviews, books, devices, CDC, FDA, NIH, Pediatrics, Primary care medicine
Leave a comment
Are the new PCSK9 cholesterol lowering drugs worth the high cost?
December 16, 2015- Interviewed by Steven E. Greer, MD
Posted in - Biotech, - NEJM, - Opinion, - Pharma, - Policy, Cardiology, CMS, FDA
Leave a comment
Martin Shkreli, CEO of Turing Pharmaceuticals, could be the Bernie Madoff of the drug industry
September 22, 2015- by Steven E. Greer, MD Making national news today was Martin Shkreli, the baby-faced, greasy-haired, disheveled-looking
Posted in - Biotech, - Pharma, Congress, FDA
Leave a comment
Rand Paul’s secret Looney Tune side revealed
http://youtu.be/AlWcDDZ1w38 February 2, 2015- By Steven E. Greer, MD People have asked me my opinion of the Republican field for 2016 and I have told them that Dr. Rand
Using Afrezza inhaled insulin with a CGM
November 3, 2014- Interviewed by Steven E. Greer, MD Inhaled insulin will make a comeback when Mannkind’s drug, Afrezza, goes on sale in early 2015.
The FDA’s new Breakthrough status for new drug applications
May 24, 2013- Interviewed by Steven E. Greer, MD Janet Woodcock, MD,
Posted in - Pharma, FDA
Leave a comment
The serious adverse events caused by topical testoserone
March 1, 2014
Posted in - Pharma, Dermatology, Diabetes and endocrinology, FDA
Leave a comment
The FDA discusses Brilinta
February 4, 2014- The WSJ is reporting today on a Johns Hopkins doctor who filed a federal
Posted in - Pharma, Cardiology, FDA
Leave a comment
Alex Rodriguez’s PED schedule
January 12, 2014- By Steven E. Greer, MD CBS’s “60 Minutes” interviewed the man, Anthony Bosch, claiming to have been the pseudo-doctor
Posted in - Opinion, - Pharma, Congress, Diabetes and endocrinology
Leave a comment
CBS allows TV doctor to make egregious claims about statins
Can a “calculator” really tell doctors who should be on Lipitor? Nortin Hadler, MD: lack of evidence for widespread statin use The risk of diabetes associated with statin drugs “You’re telling me this now?” Why the news is suddenly critical … Continue reading
Posted in - Pharma, Cardiology, Cedars Sinai
Leave a comment
New therapies for hepatitis C
November 6, 2013- Interviewed by Steven E. Greer, MD In Part 1, Sammy Saab, MD, MPH, liver disease and GI doctor from UCLA, discusses the standard of care
Super rapid acting insulin and inhaled insulin
September 9, 2013- Interviewed by Steven E. Greer, MD Jay Skyler, MD, PhD, Deputy Director of the Diabetes Research Institute at The University
Posted in - Biotech, - Pharma, Diabetes and endocrinology, Univ Miami
Leave a comment
FDA reviews the safety of Januvia, Byetta, and other GLP-1 diabetes drugs
Interviewed by Steven E. Greer, MD
Posted in - Pharma, FDA
Leave a comment
anti-PD1 and anti-PD-L1 drugs treating NSCLC
March 26, 2013 Interviewed By Steven E. Greer, MD
Posted in - Biotech, - Pharma, Oncology, UCLA
Leave a comment